Cargando…

Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom

BACKGROUND: Over 80% people with Parkinson's disease (PD; PwP) live with chronic pain. OBJECTIVE: Whether ethnic disparities in receipt of appropriate analgesia exist among PwP with chronic pain living in the United Kingdom (UK). METHODS: A retrospective datamining of an existing King's PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rukavina, Katarina, Ocloo, Josephine, Skoric, Magdalena Krbot, Sauerbier, Anna, Thomas, Omotola, Staunton, Juliet, Awogbemila, Olabisi, Trivedi, Dhaval, Rizos, Alexandra, Chaudhuri, K. Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974878/ https://www.ncbi.nlm.nih.gov/pubmed/35392300 http://dx.doi.org/10.1002/mdc3.13430

Ejemplares similares

Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
por: Rukavina, Katarina, et al.
Publicado: (2022)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Addressing the gap for racially diverse research involvement: The King's Model for minority ethnic research participant recruitment()
por: Ray Chaudhuri, K., et al.
Publicado: (2023)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
por: Martinez-Martin, Pablo, et al.
Publicado: (2017)

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
por: Rizos, A., et al.
Publicado: (2020)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

Effects of safinamide on pain in patients with fluctuating Parkinson's disease
por: Grigoriou, Sotirios, et al.
Publicado: (2021)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review
por: Zis, Panagiotis, et al.
Publicado: (2015)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2022)

Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, M. A., et al.
Publicado: (2023)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

Race/ethnic disparities in early childhood BMI, obesity and overweight in the United Kingdom and United States
por: Zilanawala, A, et al.
Publicado: (2015)

Self-reported periodontitis and C-reactive protein in Parkinson’s disease: a cross-sectional study of two American cohorts
por: Lyra, Patrícia, et al.
Publicado: (2022)

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
por: Lau, Yue Hui, et al.
Publicado: (2022)

Socioeconomic deprivation and genetic ancestry interact to modify type 2 diabetes ethnic disparities in the United Kingdom
por: Nagar, Shashwat Deepali, et al.
Publicado: (2021)

Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
por: Kharkar, Siddharth, et al.
Publicado: (2018)

Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod
por: Krbot Skorić, Magdalena, et al.
Publicado: (2022)

Gender gap in deep brain stimulation for Parkinson’s disease
por: Jost, Stefanie T., et al.
Publicado: (2022)

Evolution of phenotypic disparity in the plant kingdom
por: Clark, James W., et al.
Publicado: (2023)

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study
por: Sauerbier, Anna, et al.
Publicado: (2018)

Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders
por: Hampsey, Elliot, et al.
Publicado: (2022)

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
por: Jost, Stefanie T., et al.
Publicado: (2021)

Effect of Food Intake on Hemodynamic Parameters during the Tilt-Table Test in Patients with Postural Orthostatic Tachycardia Syndrome
por: Habek, Mario, et al.
Publicado: (2019)

Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab
por: Habek, Mario, et al.
Publicado: (2022)

The Interconnection between Carotid Intima–Media Thickness and Obesity: Anthropometric, Clinical and Biochemical Correlations
por: Bažadona, Danira, et al.
Publicado: (2023)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
por: Metta, Vinod, et al.
Publicado: (2021)

Association of Medicare Advantage Star Ratings With Racial, Ethnic, and Socioeconomic Disparities in Quality of Care
por: Meyers, David J., et al.
Publicado: (2021)

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
por: Voon, Valerie, et al.
Publicado: (2014)

Evolution of tongue somatosensory evoked potentials in people with multiple sclerosis
por: Krbot Skorić, Magdalena, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Health Status and Community Functioning Among Persons with Untreated Mental Illness
por: Snowden, Lonnie R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2aga9mpfbimkf7rtle2v80fo41